Ingenus Pharmaceuticals Llc
Ingenus Pharmaceuticals Llc appears in FDA public data with 6 recalls, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0010-2023, Class II) was initiated on September 30, 2022.
Summary
- Total Recalls
- 6
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0010-2023 | Class II | Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceut | September 30, 2022 |
| D-0374-2022 | Class II | Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC | January 10, 2022 |
| D-0146-2020 | Class II | Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 R | October 9, 2019 |
| D-1058-2019 | Class III | Diclofenac Sodium Topical Solution, 1.5% w/w, 5 FL. OZ. (150 mL) bottle, Rx Only, Manufactured for: | March 18, 2019 |
| D-0891-2018 | Class II | Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial, Rx Only, | June 8, 2018 |
| D-0890-2018 | Class II | Irinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial, Rx Only, | June 8, 2018 |